CEO SUMMARY: In Ireland, the big story in healthcare at the moment is the discovery that the nation’s cervical cancer screening program has failed hundreds of women who had pre-cancerous conditions or cervical cancer, but, as alleged in numerous court cases, their tests were inaccurate or the results not communicated to their physicians, or both.
Tag: irish labs
CEO SUMMARY: Evidently the Irish Health Service is satisfied with its decision to outsource all the nation’s cervical cancer screening tests. In recent weeks, it announced that two international laboratory companies would handle Pap testing for the next two years. Sonic Healthcare, Ltd., won a contract to perform 25% of Ireland’s 300,000 Pap tests annually.
WHEN IT COMES TO CERVICAL CANCER SCREENING IN IRELAND, health system bureaucrats have put some of the nation’s women into the perfect “Catch 22.”
As this happens, it provides another case study of why a government health system can often create coverage rules and restrictions which run contrary to common sense in patient care, while at
CEO SUMMARY: In Ireland, pathologists are asking the government to return enough Pap tests back to the country to support and sustain medical training programs in gynecologic cytology. It was 2008 when the Irish government outsourced all Pap testing to a U.S. lab company. That forced Ireland’s major cytology laboratories to shut down their cervical
IT IS PURELY COINCIDENTAL that, in this issue, you will read intelligence briefings about Pap testing in Ireland (see pages 3-5) and Massachusetts (see pages 10-15). Yet, both stories, taken together, send an important message to laboratory executives and pathologists.
Because of ongoing evolution in healthcare, laboratories must continuously innovate and improve specifically to maintain their